Category: hospital

agreement, analysis, analytics, Aussie, Australia, Australian, British, business, Business Analysis, CANADA, canadian, cannabinoid, cannabis, cbd, clinic, compliance, consumer, cooperation, cultivation, drug, England, Epidiolex, EU, europe, European, export, Federal, firm, German, Germany, global, government, growing, GW Pharma, GW Pharmaceuticals, healthcare, hospital, import, industry, insurance, insure, international, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, network, NHS, patient, pharmacies, pharmacy, pool, prescribe, prescription, producer, product, production, Quality, regulation, regulations, regulatory, retail, Sativex, state, thc, THC Global, UK, union, United Kingdom, wide, world

Will Australia’s Cannabis Program Follow Canada’s Lead?

Will Australia’s Cannabis Program Follow Canada’s Lead?

The news is intriguing in a world overwhelmed with pandemic news. THC Global, a Canadian-Aussie company now raising money and signing global […]